Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy
- 1 November 2004
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 66 (5) , 1959-1965
- https://doi.org/10.1111/j.1523-1755.2004.00982.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor, omapatrilat in healthy subjectsBritish Journal of Clinical Pharmacology, 2003
- Vasopeptidase inhibition: A new treatment approach for endothelial dysfunctionKidney International, 2003
- Vasopeptidase InhibitionHypertension, 2003
- Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized ratsKidney International, 2001
- Proinflammatory gene expression and macrophage recruitment in the rat remnant kidneyKidney International, 2000
- Endothelin antagonists in renal diseaseKidney International, 2000
- Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidneyAmerican Journal of Kidney Diseases, 1996
- A specific endothelin subtype A receptor antagonist protects against injury in renal disease progressionKidney International, 1993
- Renal endothelin gene expression is increased in remnant kidney and correlates with disease progressionKidney International, 1993
- Dietary Protein Intake and the Progressive Nature of Kidney Disease:New England Journal of Medicine, 1982